Cargando…
Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
BACKGROUND: Primary tumor resection (PTR) in metastatic colorectal cancer (mCRC) has not been suggested by guidelines, since new systemic chemotherapy options have improved overall survival. However, the effect of PTR is still controversial in mCRC. In this study, we aimed to evaluate the effect of...
Autores principales: | Ergun, Yakup, Bal, Oznur, Dogan, Mutlu, Ucar, Gokhan, Dirikoc, Merve, Acikgoz, Yusuf, Bacaksiz, Ferhat, Uncu, Dogan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053176/ https://www.ncbi.nlm.nih.gov/pubmed/32174986 http://dx.doi.org/10.4103/jrms.JRMS_1056_18 |
Ejemplares similares
-
The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer
por: Acikgoz, Yusuf, et al.
Publicado: (2021) -
Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
por: Ucar, Gokhan, et al.
Publicado: (2020) -
The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer
por: Açikgoz, Yusuf, et al.
Publicado: (2020) -
Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?
por: Ucar, Gokhan, et al.
Publicado: (2020) -
Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data
por: Caliskan Yildirim, Eda, et al.
Publicado: (2023)